|
Abbapolins as Inhibitors and Degraders of Polo-Like Kinases
Reference #: 01593
The University of South Carolina is offering licensing opportunities for Abbapolins as Inhibitors and Degraders of Polo-Like Kinases
Background:
There are no effective treatments for castration-resistant prostate cancers as all current therapies eventually fail.
Invention Description:
Novel chemicals called abbapolins are described...
Published: 7/10/2026
|
Updated: 9/14/2022
|
Inventor(s): Campbell Mcinnes, Michael Wyatt, Danda Chapagai, Jessy Stafford, Gursanker Ramamoorthy
Keywords(s): abbapolin, drug discovery, peptide, Polo Like Kinase
Category(s): Biomedical and Life Sciences, Health Sciences
|